跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tizacure 100 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tizacure 100
Approved
STANDARD
Tizacure 100
XL Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ad660138b82d39e9
Company
XL Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
ad660138b82d39e9
Drug Approval Philippines Name
Tizacure 100
Product Name
Tizacure 100
Registration Number
DRP-5694
Brand Name
Tizacure 100
Generic Name
Lamivudine
Dosage Form
Tablet
Dosage Strength
100 mg
Manufacturer
XL Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
29 June 2024
Expiry Date
21 April 2030
Pharmacologic Category
Antiviral
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ad660138b82d39e9
Type
Standard
Back to Philippines FDA Approvals